Wilmington drug research company Charles River Laboratories International Inc. said Tuesday it has agreed to buy a 75 percent ownership stake in Vital River, a Chinese provider of pharmaceutical research models and related services, for about $27 million. Charles River said the acquisition would help it expand in the fast-growing Chinese market for drug discovery and development. The transaction is expected to be completed in the first quarter of 2013.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help